Pregabalin (Lyrica) 300mg

Pregabalin 300 mg: Medicine Information and Safety Guide

Pregabalin is a prescription medicine used to manage certain types of nerve pain, as an additional treatment for specific forms of epilepsy, and for generalised anxiety disorder in adults. It acts on signalling processes within the central nervous system and may help reduce symptoms associated with these conditions when prescribed for an appropriate medical reason.

This page provides information about pregabalin 300 mg, including its recognised uses, how it works, possible side effects, medicine interactions and important precautions. It is intended to help patients understand their prescribed treatment and prepare informed questions for a doctor or pharmacist. It does not replace the patient information leaflet supplied with the exact product.

Pregabalin is a prescription-only medicine in the United Kingdom and is subject to additional controlled-drug requirements. A 300 mg product should only be used by the person for whom it has been prescribed, according to their clinician’s instructions. The strength alone does not establish whether a particular regimen is appropriate.

What Is Pregabalin 300 mg?

Pregabalin is the active ingredient in several authorised medicines. Products are available in different strengths and pharmaceutical forms, including capsules and certain tablet formulations. A product labelled 300 mg contains the stated amount of pregabalin in each unit, but the exact formulation and its instructions must be checked on the packaging and patient information leaflet.

Pregabalin belongs to a group of medicines commonly described as gabapentinoids. Although its chemical structure resembles gamma-aminobutyric acid (GABA), it does not work by simply acting as a GABA receptor agonist. Instead, pregabalin binds to the alpha-2-delta subunit of voltage-gated calcium channels in the nervous system. This influences the release of certain neurotransmitters involved in nerve signalling.

The medicine may be prescribed when a clinician determines that its potential benefits are appropriate for a patient’s symptoms and medical circumstances. It is not suitable for every type of pain, every seizure disorder or every anxiety-related condition. Its use should be based on an individual clinical assessment rather than a product description or online search result.

What Is Pregabalin Used For?

UK-authorised pregabalin products include indications for particular neurological and anxiety-related conditions in adults. The exact authorised indications should always be checked against the Summary of Product Characteristics for the specific product being prescribed.

1. Neuropathic pain

Neuropathic pain develops when nerves or the systems that carry pain signals become damaged or function abnormally. It can feel different from pain caused by a simple strain or minor injury. Some people describe burning, tingling, electric-shock sensations, shooting discomfort, unusual sensitivity to touch or persistent pain without an obvious external cause.

Examples of conditions associated with neuropathic pain include painful diabetic peripheral neuropathy and post-herpetic neuralgia, which can occur after shingles. Pregabalin is also authorised for certain forms of central neuropathic pain in adults, depending on the specific product information.

Pregabalin can reduce symptoms for some patients, but the response varies. It does not repair every underlying nerve injury, and improvement may be partial rather than complete. A clinician should review whether treatment is helping, whether adverse effects are acceptable and whether other aspects of pain management need attention.

2. Epilepsy as add-on treatment

Pregabalin is authorised as an adjunctive treatment for partial-onset seizures in adults, including seizures that may progress to bilateral convulsive activity. Adjunctive means that it is used alongside other appropriate antiseizure treatment rather than automatically replacing an existing medicine.

People receiving treatment for epilepsy should follow their prescribed plan consistently. Changing the dose, skipping treatment or stopping pregabalin suddenly can be harmful. Anyone who experiences a change in seizure pattern or has concerns about treatment should contact their epilepsy team or prescriber.

Pregabalin is not a universal treatment for all seizure types. The decision to prescribe it depends on the person’s diagnosis, current medicines, seizure history and the clinician’s assessment.

3. Generalised anxiety disorder

Generalised anxiety disorder (GAD) involves persistent, excessive worry that can affect everyday activities, concentration, sleep and overall wellbeing. Physical symptoms may include tension, restlessness and difficulty relaxing.

Pregabalin is authorised for GAD in adults in the UK for products whose licence includes this indication. It is not an appropriate self-selected remedy for ordinary stress or every form of anxiety. A healthcare professional should consider the person’s symptoms, medical history, other treatments and risk factors before prescribing it.

Psychological therapies and other approaches may also form part of an anxiety management plan. Treatment decisions should reflect the individual’s needs and preferences, with regular review of benefits, side effects and continuing clinical need.

Understanding the 300 mg Strength

The term “pregabalin 300 mg” describes a medicine strength, not a recommendation that every patient should take 300 mg at once or every day. Standard immediate-release pregabalin capsules and tablets are available in several strengths, and authorised prescribing information describes total daily doses divided into separate administrations for relevant formulations.

In UK product information, the usual total daily dose range for adults with appropriate kidney function is described as 150 mg to 600 mg per day for certain indications. That range is not a personal dosing recommendation. Starting treatment, increasing a dose, choosing an individual dose or changing the frequency requires a prescriber’s assessment. Kidney impairment can require substantial adjustment.

A 300 mg capsule may be appropriate for some established prescriptions but unsuitable for someone who is starting treatment, has reduced kidney function, experiences troublesome adverse effects or takes interacting medicines. Do not infer a dosing schedule from the product name alone.

Why formulations matter

Capsules, standard tablets and modified-release tablets are not automatically interchangeable. Modified-release products can have different instructions and dosing schedules from immediate-release formulations. The name, strength and pharmaceutical form on the prescription and dispensing label should match the product supplied.

Excipients, including ingredients that may matter to people with certain allergies or intolerances, can also differ between manufacturers. Check the leaflet for the specific product rather than relying on a description of another pregabalin brand.

How Does Pregabalin Work?

Pregabalin binds to an auxiliary subunit of voltage-gated calcium channels in the central nervous system. These channels help regulate chemical signalling between nerve cells. By influencing neurotransmitter release, pregabalin can alter certain forms of excessive or abnormal signalling.

In neuropathic pain, this action may reduce the intensity of signals associated with nerve-related discomfort. In epilepsy, it can help as an adjunctive treatment for the authorised seizure types. In GAD, it may help reduce symptoms in suitable patients.

The effects are not identical for everyone. The medicine may take time to provide noticeable improvement, and some patients may experience adverse effects before they experience a clear benefit. A prescriber should assess the balance between symptom control and tolerability throughout treatment.

Important Safety Information Before Treatment

Before prescribing pregabalin, a healthcare professional should review relevant medical conditions, other medicines, previous treatment experiences and the potential for adverse effects or dependence.

Kidney function

Pregabalin is eliminated mainly through the kidneys. People with reduced kidney function may require a lower dose or a different dosing schedule. The adjustment depends on clinical measurements and the individual’s circumstances. Anyone with kidney disease, receiving dialysis or experiencing a change in kidney function should ensure that their prescriber knows about it.

Breathing problems

Pregabalin has been associated with serious breathing difficulties, particularly in people with respiratory disease, reduced kidney function, older age or concurrent use of medicines that depress the central nervous system. Opioids, benzodiazepines and other sedating medicines can increase this risk.

Seek emergency medical help if someone taking pregabalin develops severe breathing difficulty, unusually shallow or slow breathing, extreme drowsiness or difficulty waking.

Dependence, misuse and withdrawal

Pregabalin can cause physical dependence, and misuse, addiction and withdrawal symptoms have been reported. These risks can occur even when the medicine has been taken at prescribed doses. Risk may be higher in people with a current or previous history of substance misuse or certain mental health difficulties.

Patients should use only their own prescribed medicine and should not share it with anyone else. Taking more than prescribed or combining it with sedatives to intensify its effects can be dangerous.

Stopping suddenly or reducing the dose too quickly may cause withdrawal symptoms. A clinician should plan any discontinuation and guide a gradual reduction tailored to the individual. The appropriate pace may differ according to treatment duration, the current dose and the person’s response.

Pregnancy and breastfeeding

Pregabalin treatment during pregnancy requires careful medical review because available evidence has raised concerns about possible risks to an unborn baby. Anyone who is pregnant, planning a pregnancy or could become pregnant should discuss treatment with their prescriber before making changes.

Patients should also discuss breastfeeding before starting or continuing treatment. Do not stop an established prescription abruptly because of a pregnancy concern; seek prompt advice from the prescribing clinician so that the benefits, risks and alternatives can be considered safely.

Mental health and mood changes

Changes in mood, unusual behaviour or thoughts of self-harm need prompt attention. People with a history of depression, suicidal thoughts or other mental health conditions should discuss this history with their clinician before treatment begins.

Urgent medical assistance is necessary if someone develops suicidal intent, severe confusion or another immediate mental health crisis.

Possible Side Effects of Pregabalin 300 mg

Not everyone experiences side effects, and their severity can vary. Some adverse effects are more noticeable when treatment starts or after a dose change. The list below is not exhaustive; consult the patient information leaflet supplied with the exact product.

Commonly reported effects

• Dizziness or a feeling of unsteadiness.
• Sleepiness or drowsiness.
• Headache.
• Blurred vision or other visual disturbances.
• Difficulty concentrating or feeling mentally slowed.
• Swelling of the hands, feet or ankles.
• Weight gain or increased appetite.
• Dry mouth, nausea or constipation.
• Problems with coordination or balance.
• Fatigue or a feeling of weakness.

Tell your prescriber if side effects persist, interfere with everyday activities or make it difficult to take treatment as directed. Do not increase, reduce or discontinue the medicine without appropriate advice.

Serious side effects and warning signs

Some symptoms need urgent assessment rather than routine review. These include severe breathing problems, facial or throat swelling, a severe allergic reaction, significant new suicidal thoughts and a serious skin reaction involving a spreading rash, blistering or sores affecting the mouth or eyes.

Facial, lip, tongue or throat swelling can indicate angioedema. Stop taking the medicine and obtain emergency medical assistance if this occurs, following emergency-service advice.

Pregabalin has also been associated with rare but serious skin reactions. A severe or rapidly progressing rash, particularly with fever, blisters or mucosal involvement, needs urgent medical assessment.

Suspected overdose, especially when accompanied by severe sleepiness, reduced consciousness or breathing problems, should be treated as an emergency. Do not wait for symptoms to become more pronounced.

Pregabalin Interactions: Medicines and Alcohol

Always tell the prescriber and pharmacist about prescription medicines, non-prescription products, supplements and any substances used recreationally. A complete list helps identify possible interactions and overlapping side effects.

Opioid medicines

Combining pregabalin with opioids, such as morphine or oxycodone, may increase sedation and the risk of respiratory depression. The combination may sometimes be prescribed after a careful assessment, but it requires particular caution and appropriate monitoring.

Benzodiazepines and other sedating medicines

Medicines that cause drowsiness or suppress central nervous system activity can increase the effects of pregabalin. Examples include certain sleeping medicines, benzodiazepines and other sedatives. The prescriber should review the combination rather than assuming that separately prescribed medicines are automatically safe to use together.

Alcohol

Alcohol can worsen dizziness, drowsiness and impaired coordination. It may also contribute to dangerous sedation when used with other central nervous system depressants. The safest course is to ask a clinician or pharmacist about alcohol and follow the product leaflet’s advice.

Other medicines and health conditions

Tell the clinician about medicines that may cause constipation or other effects that overlap with pregabalin, and about any history of kidney disease, respiratory problems or falls. A pharmacist can help review the full medicine list and explain whether any additional monitoring is needed.

Driving, Operating Machinery and Everyday Activities

Pregabalin can cause dizziness, sleepiness, blurred vision and reduced concentration. These effects may affect driving, cycling, using tools or operating machinery. Patients should not drive or undertake potentially hazardous activities until they know how the medicine affects them and can do so safely and legally.

People who experience balance problems should take care when standing up, walking on uneven surfaces or using stairs. Anyone who has a fall, repeated near-falls or persistent dizziness should tell their healthcare professional.

Patients should follow UK driving rules and any specific advice from their prescriber. Feeling accustomed to a medicine does not guarantee that driving performance is unaffected.

Taking Pregabalin Responsibly

Use pregabalin exactly as directed on the dispensing label and by the prescribing clinician. Do not use the strength shown on a product page to decide how much to take, how often to take it or whether to change an established regimen.

If instructions are unclear, ask the dispensing pharmacist to explain them before taking the medicine. Do not share capsules or tablets, use another person’s supply, or take extra medicine to compensate for symptoms that are not adequately controlled.

If a dose is missed

Follow the instructions in the patient information leaflet or contact a pharmacist for advice about a missed dose. Do not double a dose to make up for one that was missed. If pregabalin is being used for epilepsy, consistent treatment is particularly important because missed doses can affect seizure control.

If too much has been taken

Seek urgent medical advice if more pregabalin than prescribed has been taken. Overdose can cause sleepiness, confusion, agitation, seizures or reduced consciousness, and may be more dangerous when other sedating substances are involved.

If the person is unconscious, difficult to wake or having breathing difficulties, call 999. Do not induce vomiting or attempt to manage a serious overdose at home.

Storage and Disposal

Keep pregabalin in its original packaging where possible, following the storage instructions supplied with the specific product. Store it securely, away from children and anyone for whom it has not been prescribed.

Do not use a medicine beyond its expiry date. If the packaging is damaged, the label is unclear or the product does not match the prescription, contact the dispensing pharmacy before use.

Do not dispose of unwanted or expired medicines in household waste or wastewater unless local instructions specifically direct you to do so. Ask a community pharmacist how to return them safely. Because pregabalin is a controlled medicine, follow the pharmacist’s advice on handling and disposal.

Pregabalin 300 mg: Frequently Asked Questions

Is pregabalin 300 mg available in the UK?

Yes. UK-authorised pregabalin products include 300 mg capsules and, for certain products, 300 mg tablets. Availability can differ by manufacturer, formulation and supplier. Check the exact product’s authorisation and packaging rather than assuming all products are identical.

Is pregabalin 300 mg a prescription-only medicine?

Yes. Pregabalin is a prescription-only medicine in the UK. It is also a controlled drug, so its prescribing, dispensing and possession are subject to applicable legal requirements. It should only be supplied through a lawful, appropriate prescribing and dispensing process.

What conditions can pregabalin treat?

Depending on the authorised product, pregabalin is used for peripheral and central neuropathic pain in adults, as add-on treatment for partial-onset seizures in adults, and for generalised anxiety disorder in adults. It is not suitable for every kind of pain, epilepsy or anxiety.

Does the 300 mg strength mean one capsule should be taken every day?

No. The product strength does not determine an individual’s dosing schedule. The appropriate amount and frequency depend on the prescription, the condition being treated, kidney function and other clinical factors. Follow the dispensing label and ask the prescriber or pharmacist if anything is unclear.

Can pregabalin cause dependence?

Yes. Physical dependence, addiction and withdrawal symptoms are recognised risks. Do not increase the dose independently, share the medicine or stop abruptly. Discuss concerns about dependence with a healthcare professional, who can review treatment and plan changes safely.

Can pregabalin be taken with other medicines?

Sometimes, but the combination needs review. Opioids, benzodiazepines and other medicines that cause sedation may increase the risk of dangerous drowsiness or breathing problems. Give your prescriber and pharmacist a complete list of medicines and supplements before treatment.

Can I stop taking pregabalin when I feel better?

Do not stop suddenly without medical guidance. Abrupt discontinuation can lead to withdrawal symptoms and may be especially risky for people receiving treatment for epilepsy. The prescriber should decide whether treatment remains necessary and, when appropriate, create an individual gradual reduction plan.

What should I do if pregabalin causes severe side effects?

Contact a healthcare professional promptly if side effects are troublesome or worsening. Severe breathing difficulty, facial or throat swelling, a serious skin reaction or an immediate risk of self-harm requires emergency help.

Further Reading and Authoritative References

For reliable information about pregabalin, consult recognised UK health services and the official product information for the exact medicine supplied.

• NHS: About pregabalin — an overview of uses, common effects and important safety information.
• NHS: How and when to take pregabalin — patient guidance on prescribed use and available strengths.
• MHRA / GOV.UK: Pregabalin and gabapentin safety and controlled-drug requirements — official information about dependence and legal controls. If the URL has changed, search the GOV.UK website for the exact article title.
• electronic Medicines Compendium (emc) — search for the specific brand and strength to read its Summary of Product Characteristics and Patient Information Leaflet.
• Medicines and Healthcare products Regulatory Agency (MHRA) — UK regulatory and medicine safety information.

Important Information for Patients

This page is intended for general educational purposes and should not be used to diagnose a condition or determine an individual treatment plan. Medicine authorisations, formulations and prescribing instructions can differ between products. Always read the leaflet supplied with your medicine and consult an appropriately qualified healthcare professional about personal medical questions.

Pregabalin should only be used by the person for whom it was prescribed. Do not obtain it through an unverified supplier, share it with another person or change the prescribed dose without medical advice. If you are unsure about the identity, strength, origin or legal supply of a product, consult a registered pharmacist before using it.